
Human Immunodeficiency Virus Treatment and Prevention for Pregnant and Postpartum Women in Global Settings
Review and description of current HIV prevention, specifically PMTCT, strategies in pregnant and breastfeeding women, including ART during pregnancy/breastfeeding and lifelong ART for women living with HIV, PrEP use during pregnancy/breastfeeding for women not living with HIV, and integrating other HIV prevention services with PrEP. However, more work needs to be done in implementing evidence-based practices (as listed above) in high-burden, low-resource settings. Possible strategies include integration of HIV testing with routine antenatal care, differentiated care models, and postnatal adherence clubs.
Resource Details
- Study Type
- Review
- Year
- 2022
- Population
- Pregnant & Postpartum Women
- Author
- Saidi F, Chi BH
- Source
- Obstet Gynecol Clin N Am
More Publications & Resources


PrEP and PEP Guidelines-Zambia

PrEP Lenacapavir Implementation Guidelines

Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)

Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP

Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics

Lenacapavir Provider Tools and Job Aids

PrEP Drug Interactions

Zambia PrEP Training Materials for Clinicians and Community Mobilisers

HIV Prevention Ambassador Training Package and Toolkit

Zambia Consolidated Guidelines for Treatment and Prevention of HIV Infection

National Guidelines for the Management of HIV and AIDS
No results found.
